Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00486460
Status:
UNKNOWN
Last Update Posted:
2007-06-14
First Post:
2007-06-13
Brief Title:
Phase III Trial of Gemcitabine Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Tel-Aviv Sourasky Medical Center
Organization Data
Organization:
Tel-Aviv Sourasky Medical Center
Class:
OTHER_GOV
Study ID:
TASMC-07-NA-132-CTIL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None